Interestingly, one reported patient who received a dendritic cell vaccine generated from autologous GBM tumor lysate had a robust CD8+ T-cell response to the HCMV epitope pp65 after one injection of the vaccine (31). This evidence concerns the gene CD8A and neoplasm.